Federal contractor · LAKEWOOD, CO

TERUMO BCT INC

TERUMO BCT INC received $790.3K in federal contract obligations in FY2026, on 19 awards (−33% vs FY2025). Since FY2017: $15.5M. Its largest customer was Department of the Army ($497.6K).

Obligations · FY2026: $790.3K
New awards: 19
Sole-source: 100%
Single offer: 0.0%

UEI: WCEMNMCYNBW1
Parent company: TERUMO CORPORATION

Other than small businessForeign-owned

Open in the contracts explorer Relationship graph

Company family

Grouped from reported parent companies (UEI) and, where marked, AI judgments that two records name the same organization or group.

Part of the TERUMO BCT BIOTECHNOLOGIES, LLC company family: 3 registered entities, $1.7M in FY2026 together. See the family

TERUMO BCT BIOTECHNOLOGIES, LLCLAKEWOOD, CO · Family page
AI name match · 99%$16.4K
TERUMO CARDIOVASCULAR SYSTEMS CORPORATIONANN ARBOR, MI
AI name match · 99%$932.1K

AI-inferred: entity-match@1 · Analisa AI · 2026-10-05

Spending by fiscal year

Obligations per federal fiscal year (October–September).

3.9MFY2017
1.5MFY2018
1.6MFY2019
2.1MFY2020
494.6KFY2021
953.4KFY2022
1.5MFY2023
1.4MFY2024
1.2MFY2025
790.3KFY2026

Top buying agencies

Obligations in FY2026.

Department of the Army$497.6K63%
3 awards
Defense Health Agency$158.2K20%
6 awards
Department of Veterans Affairs$140.1K18%
4 awards
Defense Logistics Agency-$1,2340.0%
1 awards
National Institutes of Health-$4,3270.0%
5 awards

What was bought · Where the work was performed

Obligations in FY2026.

What was bought

Health & medical$509.3K61%
Equipment maintenance$304.1K37%
IT & telecom$15K1.8%

Where the work was performed

Integrity signals

Shares of the year's obligations, next to the country's.

Low competition100%
US 39% · $790.3K
Sole-source awards100%
US 30% · $849.2K
Single-offer competitions0.0%
US 8.7% · -$58.9K
Urgency justifications0.0%
US 5.1% · $0

A signal is a reason to look closer, not evidence of wrongdoing: most sole-source awards are lawful and justified.

Agencies awarding it sole-source contracts

Department of the Army$497.6K
Department of Defense · 1 awards
Defense Health Agency$158.2K
Department of Defense · 1 awards
Department of Veterans Affairs$140.1K
Department of Veterans Affairs · 1 awards
National Institutes of Health$53.3K
Department of Health and Human Services · 1 awards

Largest awards

5 EACH AUTOMATED APHERESIS EQUIPMENT$407.9K
Department of the Army· Jefferson County, CO· Health & medical· Jun 4, 2026 – Jun 4, 2026· W81K0026PA130
BLOOD SAMPLING$275.6K
Defense Health Agency· Montgomery County, MD· Health & medical· Sep 18, 2025 – Mar 11, 2026· HT001425PE074
MEDICAL EQUIPMENT SERVICES MAINTENANCE$148.3K
Defense Health Agency· Montgomery County, MD· Equipment maintenance· Jan 24, 2024 – Jan 13, 2026· HT001424P0026
TRIMA CELL PROCESSORS$140.4K
Department of the Army· El Paso County, CO· Equipment maintenance· Aug 8, 2023 – May 20, 2026· W81K0023P0065
SPECTRA OPTIA APHERESIS MACHINE$102.7K
Department of Veterans Affairs· Jefferson County, CO· Health & medical· May 29, 2026 – May 29, 2026· 36C24926P0381
FY25 TRIMA SN: 1T05022-81000$87.2K
Department of the Army· Bell County, TX· Equipment maintenance· May 8, 2024 – Feb 11, 2026· W81K0024P0090
TERUMO APHERESIS EQUIPMENT PREVENTATIVE MAINTENANCE SERVICES$84.8K
National Institutes of Health· Montgomery County, MD· Equipment maintenance· Aug 6, 2024 – Aug 19, 2026· 75N90024P00567
TERUMO BCT, INC:1109771 [19-012434]$77.3K
National Institutes of Health· Montgomery County, MD· Other equipment & supplies· Aug 6, 2019 – Apr 13, 2026· 75N90019P00647

Subawards

Matched by Unique Entity ID: the first-tier subawards this organization reported as a prime recipient, and those primes reported paying it.

As a prime: who it pays · FY2026

No subawards reported as a prime in FY2026.

As a sub-recipient: who pays it · FY2026

No subawards reported to it in FY2026.

Primes report first-tier subawards of $30,000 or more themselves, and many go unreported (GAO-24-106214). Reporting moved from FSRS to SAM.gov in March 2025 and fewer sub-contracts have been reported since. Amounts are what primes reported; they are never added to prime award totals.

Source: Subawards (first-tier sub-contracts and sub-grants reported under FFATA) (U.S. Department of the Treasury, USAspending.gov (reports filed in SAM.gov, formerly FSRS)), data current to Oct 9, 2026, loaded Oct 9, 2026 · Subawards loaded from FY2021.

Teaming partners

Companies this company reported paying, primes that reported paying it, from FFATA subaward reports.

Companies it pays

No subawards reported to other companies.

Primes that pay it

1 company · $86K reported

LEIDOS, INC.$86K
RESTON, VA · 1 subaward · Scientific research and development services

Competitors

Companies that win from the same buyers in the same markets: obligations by agency and industry compared over the last three fiscal years.

Compared on 20 markets (agency × industry), FY2024–FY2026.

LIVANOVA USA INC$5.3M+23% in FY2026
HOUSTON, TX · 2 entities · 47% of this company's obligations are in markets they both serveVeterans Affairs · Electronic and precision equipment repair and maintenanceVeterans Affairs · Medical equipment and supplies manufacturingVeterans Affairs · Navigational, measuring, electromedical, and control instruments manufacturing+4 more
MIZUHO ORTHOPEDIC SYSTEMS, INC.$2.4M+74% in FY2026
UNION CITY, CA · 30% of this company's obligations are in markets they both serveVeterans Affairs · Medical equipment and supplies manufacturingVeterans Affairs · Electronic and precision equipment repair and maintenanceDefense Health Agency · Electronic and precision equipment repair and maintenance+2 more
ALCON VISION, LLC$9.1M−23% in FY2026
FORT WORTH, TX · 54% of this company's obligations are in markets they both serveVeterans Affairs · Electronic and precision equipment repair and maintenanceVeterans Affairs · Medical equipment and supplies manufacturingArmy · Medical equipment and supplies manufacturing+4 more

Showing the top 3 of 25 competitors. Open the profile for the full list.

Who sells to the same buyers in the same markets, not who wins against whom on a given contract. Prime contract obligations by the agency and NAICS code of each award; subawards are never added. A company is a family of legal entities, joined by parent UEI or, in part, by an AI reading of names.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 9, 2026, loaded Oct 9, 2026 · FY2024–FY2026.

Lobbying and PAC activity

Organizations in House lobbying disclosures and FEC records whose names an AI judgment matched to this company. Those records carry no identifier shared with contracts, so every match is by name.

Across the company family of TERUMO BCT BIOTECHNOLOGIES, LLC (3 recipients).

Matched organizations

TERUMO BCT, INC.AI match · 100%

Lobbying · 2025: $80K; 8 reports
Lobbying · 2023–2026: $800K; $730K in its own reports

Lobbying by year

2023$390K
7 reports
2024$290K
6 reports
2025$80K
8 reports
2026$40K
4 reports

Top issues

Trade (domestic and foreign)20 reports
Medicare and Medicaid18 reports
Health issues10 reports

Who was contacted

U.S. HOUSE OF REPRESENTATIVES23 reports
U.S. SENATE23 reports
Centers For Medicare and Medicaid Services (CMS)5 reports
Health & Human Services - Dept of (HHS)5 reports
Bureau of Industry and Security (BIS)3 reports
Environmental Protection Agency (EPA)3 reports
White House Office3 reports
Office of Management & Budget (OMB)2 reports
Executive Office of the President (EOP)1 reports
Food & Drug Administration (FDA)1 reports

Houses of Congress and federal agencies the reports list as contacted (a report names every one for all its issues).

Lobbying firms hired

JEFFREY J. KIMBELL & ASSOCIATES, INC.$270K
14 reports

Registrants who are individuals are counted, not named.

PACs sponsored

TERUMO BCT, INC.$0 raised this cycle

PACs these organizations sponsor (connected organizations in FEC records). A PAC gives employees' and members' voluntary contributions, not the company's own money.

Lobbying amounts are the filers' own good-faith estimates on quarterly LD-2 reports (the law asks for amounts rounded to $10,000; under $5,000 need not be itemized), latest amendment only. When an organization files its own report, it replaces what outside firms report for it that quarter. Matches are by name. Lobbying and political giving are legal and public: they show engagement with government, not influence over any award. Correlation is not influence: these organizations' lobbying and their contracts are shown side by side, and nothing here implies either affected the other.

Source: Lobbying disclosures (LD-1 registrations, LD-2 quarterly reports, LD-203 contribution reports) (Clerk of the U.S. House of Representatives), data current to Oct 9, 2026, loaded Oct 9, 2026 · 2023–2026.

Source: Committees, candidates and committee contributions to candidates (Federal Election Commission), data current to Oct 9, 2026, loaded Oct 9, 2026 · 2026, 2024, 2022.

Matches: Analisa AI name judgments (entity-match@1), updated Oct 5, 2026.

Congress: members and bills

Through the organizations matched to this company: members of Congress whose campaigns received contributions from their PACs, and the bills their lobbying reports named. Shown beside the company's contracts as a comparison, not a cause.

Bills named in its lobbying reports

H.R. 1796 · Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 20256 reports
119th Congress · Introduced · 2025–2026
S. 735 · Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 20256 reports
119th Congress · Introduced · 2025–2026
H.R. 1509 · Accelerating Kids’ Access to Care Act of 20254 reports
119th Congress · Introduced · 2025
S. 752 · Accelerating Kids’ Access to Care Act4 reports
119th Congress · Introduced · 2025
S. 1852 · Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 20233 reports
118th Congress · Reported by committee · 2023–2024
S. 721 · Sickle Cell Disease Comprehensive Care Act3 reports
119th Congress · Introduced · 2025
H.R. 7432 · Sickle Cell Disease Comprehensive Care Act1 report
118th Congress · Introduced · 2024

9 of 25 reports (2023–2026) name at least one bill. Bills and resolutions the current reports name in their issue descriptions, by number of reports. A report names what it lobbied on, not which side it took.

Amounts, members and bills are as recorded, shown side by side. They say nothing about why a contribution was made, how a member voted or what a report sought. A bill number written in a report is read as the measure of the Congress its context points to (a law's number, the Congress written next to it, the title), else of the Congress then sitting.

Source: Committees, candidates and committee contributions to candidates (Federal Election Commission), data current to Oct 9, 2026, loaded Oct 9, 2026.

Source: Lobbying disclosures (LD-1 registrations, LD-2 quarterly reports, LD-203 contribution reports) (Clerk of the U.S. House of Representatives), data current to Oct 9, 2026, loaded Oct 9, 2026.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 9, 2026, loaded Oct 9, 2026.